Psychotropic medication costs among youth with private insurance in 1998

Psychiatric Services

Volumn 52, Issue 2, 2001, Pages 152-

  Stein, B D ^a   Sturm, R ^a   Kapur, K ^a   Ringel, J ^a  

^a RAND CORPORATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; ANXIOLYTIC AGENT; CENTRAL STIMULANT AGENT; NEUROLEPTIC AGENT; PSYCHOTROPIC AGENT;

HEALTH CARE COST; HEALTH INSURANCE; HEALTH SERVICE; MENTAL HEALTH; SHORT SURVEY; ADOLESCENT; ADULT; AGE; AGED; ARTICLE; CHILD; COMPARATIVE STUDY; DRUG COST; ECONOMICS; FEMALE; HUMAN; INFANT; MALE; MIDDLE AGED; ORGANIZATION AND MANAGEMENT; PRESCHOOL CHILD; STATISTICS; UNITED STATES;

ADOLESCENT; ADULT; AGE FACTORS; AGED; CHILD; CHILD, PRESCHOOL; DRUG COSTS; FEMALE; HUMANS; INFANT; INSURANCE, PHARMACEUTICAL SERVICES; MALE; MIDDLE AGED; PRIVATE SECTOR; PSYCHOTROPIC DRUGS; UNITED STATES;

EID: 0035144352     PISSN: 10752730     EISSN: None     Source Type: Journal    
DOI: 10.1176/appi.ps.52.2.152     Document Type: Short Survey

References (3)

1. Patterns of antidepressant use in youths with Medicaid insurance
2. Trends in the prescribing of psychotropic medications to preschoolers
3. Psychotherapeutic medication patterns for youths with attention-deficit/hyeractivity disorder